Results 11 to 20 of about 27 (26)

HLA-B*5701 frequency n Chilean HIV-infected patients and in general population

Brazilian Journal of Infectious Diseases, 2010
Helena Poggi
exaly  

Peptide binding specificities of HLA-B*5701 and B*5801

Science China Life Sciences, 2012
Hu Mei
exaly  

Prevalence of HLA-B*5701 in HIV-Infected Patients in Spain (Results of the EPI Study)

HIV Clinical Trials, 2009
Federico Pulido
exaly  

Cost-effectiveness analysis of HLA-B*5701 typing in the prevention of hypersensitivity to abacavir in HIV+ patients in Spain

Enfermedades Infecciosas Y Microbiología Clínica, 2010
Oscar de la Calle-Martin
exaly  

Should HLA‐B*5701 Screening Be Performed in Every Ethnic Group before Starting Abacavir?

Clinical Infectious Diseases, 2009
Wan Beom Park, Kyoung-Ho Song, Hee-Chang Jang   +2 more
exaly  

Prospective epidemiological study of the prevalence of human leukocyte antigen (HLA)‐B * 5701 in HIV‐1‐infected UK subjects

HIV Medicine, 2010
exaly  

HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin

Nature Genetics, 2009
Ann K Daly, Pallav Bhatnagar, Yufeng Shen   +2 more
exaly  

Genetic detection of HLA-B*5701 allele for prediction of Abacavir hypersensitivity among HIV-positive patients in Polish population

HIV and AIDS Review, 2009
Magdalena Marczyńska
exaly  

HLA-B*5701 typing by sequence-specific amplification: validation and comparison with sequence-based typing

Tissue Antigens, 2005
exaly  

HLA-B*5701 typing: evaluation of an allele-specific polymerase chain reaction melting assay

Tissue Antigens, 2007
exaly